No way Mr. Perry leaves ImmunoGen for InVivo unless he sees InVivo as a solid growing company in the future.
Gerald Perry was hired in January 2009 when Immunogen’s stock price was under $4.50. On the day before his resignation the stock price was $16.48. So Immunogen’s stock price more that tripled during his time there.
Gregory D. Perry - Base Pay
$348,708 Bonus + Incentive Comp
$120,339 Total Cash Compensation
Stock Award Value
$0 Option Award Value
$921,000 Total Equity
Total for 2012 compensation was 1.3 million.
I love the fact we have some management related to Biogen Idec.
Biogen Idec helped create an industry that has touched countless lives. We were among the world's first biotechnology companies, and today we are the oldest independent biotech firm in the world. At Biogen Idec, we are proud of our more than 30 years of contributions to the biotechnology industry and look forward to continuing to shape the future of an industry that transforms scientific discovery into advances in patient care.
Biogen Idec (BIIB) closed at $228.86 today.
Kenneth DiPietro has been appointed as a member of the Board’s Audit Committee.
Scroll down to view Kenneth DiPietro…
Google: "Biogen Idec: About Us: Management"
John A. McCarthy, Jr. has been appointed as non-executive Chairman of the Board.
The Value of a Non-Executive Chaiman…
Google: "The Value of a Non-Executive Chairman"